baber/WOPTO huggingface dataset:
Patent WO-2011053003-A2 (WO)
Title: Gastric-retentive sustained release formulation containing pregabalin, polyethyleneoxide and pva-peg graft copolymer
Inventor: CHO IL HWAN
IPC: A61K9/22
Filed: 2010-10-28
Abstract: The present invention relates to a gastric-retentive sustained release formulation containing pregabalin or a pharmaceutically acceptable salts thereof, polyethyleneoxide, and polyvinylalcohol-polyethyleneglycol graft copolymer, in which a swelling property and floatability of matrix is improved by using a polyethyleneoxide and polyvinylalcohol-polyethyleneglycol graft copolymer, thereby controlling the release of the drug.
Patent WO-2012067401-A2 (WO)
Title: 치열교정기구 및 이를 갖는 치열교정시스템
Inventor: KIM SEONG HOON
IPC: A61C7/30
Filed: 2011-11-15
Abstract: 본 발명은: 치열교정시술시에 악골에 정착되는 고정 앵커와의 연결이 가능한 교정 와이어를 갖는 치열교정기구를 개시한다. 여기서 상기 교정 와이어는; 상기 고정 앵커와의 연결이 가능한 연성 재질의 제1와이어, 그리고 상기 제1와이어에 고정되어 상기 제1와이어에서 연장되는 경성(Hardness) 재질의 제2와이어를 포함하여 구성된다. 본 발명에 따른 치열교정기구에 의하면, 환자, 특히 잇몸에 대한 부담감이 적고 설치가 쉬우며 다양한 시술조건에 대응하여 형상변경이 용이하므로 적용성이 우수하며, 탄성부재가 부가됨에 따라 견인을 원하는 치아에 반작용의 작용없이 정확하게 견인력을 제공하여 치열의 효과적인 이동이 가능하고 치열교정을 위한 시술기간을 줄일 수 있으며 시술기간 동안 치아의 수직위치를 안정적으로 유지하여 치열교정의 정확성 및 안정성을 향상시킬 수 있다.
Patent WO-2012134054-A2 (WO)
Title: Bois artificiel ayant une couche élastique
Inventor: KIM DONG JIN
IPC: B27D1/04
Filed: 2012-02-14
Abstract: La présente invention concerne un bois artificiel ayant une couche élastique, une couche de bois artificiel et la couche élastique formée sur un côté de la couche de bois artificiel étant formées d'une seule pièce. Selon la présente invention, étant donné que la couche élastique formée à partir d'un matériau de caoutchouc est mise en œuvre sur la surface supérieure du bois artificiel, il est possible d'augmenter la surface de contact lors de la marche et ainsi d'améliorer la performance d'anti dérapage.
Patent WO-2012128478-A2 (WO)
Inventor: JUNG YOUNG SUK
IPC: G06V30/224
Filed: 2012-02-20
Abstract: La présente invention concerne un système et un procédé d'authentification sur base d'une image. L'authentification d'un utilisateur est effectuée par le terminal de communication mobile préenregistré d'un utilisateur transmettant à un serveur d'authentification une clé d'authentification correspondant à une image d'authentification. Dans le système d'authentification sur base d'une image d'après la présente invention, un système d'authentification d'une entité terminale comprend un dispositif informatique permettant de procéder à une première authentification par l'intermédiaire d'une communication avec un système de services en ligne, ainsi qu'un terminal de communication mobile permettant de procéder à une seconde authentification, et il comprend en outre : une unité d'enregistrement d'un terminal de communication mobile qui enregistre les informations sur l'entité terminale requises pour la seconde authentification, et un terminal de communication mobile mettant en correspondance les informations sur l'entité terminale ; une unité de production d'une clé d'authentification qui produit une seconde clé d'authentification délivrée à l'entité terminale dans laquelle la première authentification est achevée ; une unité de production d'une image d'authentification qui produit une image d'authentification correspondant à la seconde clé d'authentification produite et transmet l'image d'authentification à des fins d'affichage sur le dispositif informatique de l'entité terminale dans laquelle la première authentification est achevée par l'intermédiaire du système de services en ligne ; et une unité de vérification d'authentification qui vérifie la seconde clé d'authentification provenant du terminal de communication mobile activé après l'activation du terminal de communication mobile enregistré dans l'entité terminale dans laquelle la première authentification est achevée.
Patent WO-2012134233-A2 (WO)
Title: Sulphamide derivative having an adamantyl group and a pharmaceutically acceptable salt thereof
Inventor: KIM KI YOUNG
IPC: C07C307/06
Filed: 2012-03-30
Abstract: Provided is a sulphamide derivative having an adamantyl group, represented by the accompanying chemical formula 1, or a pharmaceutically acceptable salt thereof. The sulphamide derivative suppresses the activity of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), and is useful in the treatment of various diseases that are mediated by 11β-HSD1.
Patent WO-2013042927-A2 (WO)
Title: 키패드 노출형 휴대용 단말기
Inventor: KIM YOUNG JUN
IPC: H04B1/38
Filed: 2012-09-19
Abstract: 본 발명은 키패드 노출형 휴대용 단말기에 관한 것으로서, 더욱 상세하게는 본체부에 내장되는 키패드부를 노출시켜 노출된 키패드부를 통해 문자 또는 숫자 등을 입력할 수 있게 하여 본체부의 패널에 표시되는 화면 데이터를 기존 화면 크기를 유지하면서도 문자 또는 숫자 등을 수정하거나 입력할 수 있도록 하는 키패드 노출형 휴대용 단말기에 관한 것이다.
Patent WO-2017034242-A2 (WO)
Title: Novel catechol derivative and pharmaceutical composition comprising same
Inventor: KIM HWAN MOOK
IPC: A61K31/381
Filed: 2016-08-19
Abstract: The present invention relates to a compound represented by chemical formula 1 or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of autophagy-related diseases.
Patent WO-2017160052-A2 (WO)
Title: Appareil et procédé d'émission de signaux de référence de sondage dans des systèmes de communication
Inventor: PAPASAKELLARIOU ARIS
IPC: H04L1/00
Filed: 2017-03-14
Abstract: La présente invention concerne un système de communication pré-5 ième  génération (5G) ou 5G conçu pour prendre en charge des débits de données supérieurs à ceux d'un système de communication 4 ième  génération (4G), tel un système Long Term Evolution (LTE). Selon divers modes de réalisation, la présente invention concerne un appareil d'un équipement utilisateur (UE) conçu avec plusieurs cellules de desserte permettant un duplex par répartition dans le temps (TDD). L'appareil comprend au moins un émetteur-récepteur et au moins un processeur fonctionnellement couplé audit au moins un émetteur-récepteur. Ledit au moins un émetteur-récepteur est conçu pour recevoir des informations de commande de liaison descendante (DCI) utilisant un format de DCI qui contient des premières informations destinées à une instruction de commande de puissance d'émission (TPC) et des secondes informations destinées à une demande de signal de référence de sondage (SRS) et pour émettre un SRS sur la base des DCI.
Patent WO-2020153769-A2 (WO)
Title: Method for producing heavy oil with reduced odor induction and harmful vapor, and system therefor
Inventor: CHO JOUNGMO
IPC: B01F23/00
Filed: 2020-01-22
Abstract: The present invention relates to a method for producing heavy oil in which substances present in the heavy oil that cause a plurality of odors and harmful components including fine dust are removed in advance, in order to prevent the generation of odors and harmful components including fine dust that may occur in a process using heated heavy oil as a raw material, and to a system therefor. The production method comprises: a heavy oil heating step of heating heavy oil stored in a heavy oil reforming reactor to a reforming reaction temperature; a carrier gas supply step of dispersing and supplying a carrier gas into the heated heavy oil stored in the heavy oil reforming reactor; and an induced odor and harmful component discharge step of discharging, together with the carrier gas, induced odors and harmful components present in the heated heavy oil in the heavy oil reforming reactor to the outside of the heavy oil reforming reactor. In addition, the system comprises: the method for producing heavy oil with reduced odor induction and harmful components; the heavy oil reforming reactor; a carrier gas supply unit; a carrier gas dispersion unit; and an induced odor and harmful component separation unit.
Patent WO-2021066461-A2 (WO)
Title: Exhaust gas treatment apparatus
Inventor: HONG IL-GU
IPC: F01N3/04
Filed: 2020-09-28
Abstract: An exhaust gas treatment apparatus is disclosed. An exhaust gas treatment apparatus according to one embodiment of the present invention comprises: a gas/liquid reactor, which makes an emission-regulated gas, included in exhaust gas, come in contact with a treatment solution, thereby removing, by absorption, the emission-regulated gas; a treatment solution supply tank for supplying the treatment solution to the gas/liquid reactor; and a gas/liquid separation treatment solution regeneration unit for regenerating a waste treatment solution, which is the treatment solution having absorbed the emission-regulated gas, with a treatment solution that has not absorbed the emission-regulated gas, and supplying a regenerated treatment solution to the treatment solution supply tank, wherein the gas/liquid separation treatment solution regeneration unit comprises a gas/liquid separation membrane through which gas passes but liquid cannot pass, so that the gas/liquid separation membrane is divided into a liquid flow channel through which the waste treatment solution flows and a gas flow channel through which the emission-regulated gas flows, and the emission-regulated gas, which is absorbed in the waste treatment solution, flows through the liquid flow channel so as to pass through the gas/liquid separation membrane and move to the gas flow channel having a low partial pressure for the emission-regulated gas, and thus the emission-regulated gas can be separated from the treatment solution.
Patent WO-2012002791-A2 (WO)
Title: Système de détection et d'enregistrement de mouvements engendrés par des maladies et des médicaments, faisant intervenir des micro-capteurs électromécaniques
Inventor: BUSTAMANTE BELLO MARTIN ROGELIO
Filed: 2011-06-28
Abstract: La présente invention concerne un système de détection et d'enregistrement de mouvements humains, également applicable à des animaux ou d'autres systèmes biologiques. Ledit système comprend en outre un sous-système de diffusion et manipulation d'informations, et permet de traiter et de transmettre les informations à des équipements informatiques externes. Ce système se caractérise en ce qu'il fait intervenir des micro-capteurs électromécaniques (tels que des micro-accéléromètres) pour réaliser les mesures, avec un agencement de capteurs qui, du fait du poids minime desdits capteurs, n'interfère pas avec le mouvement de l'objet à étudier et, par conséquent, avec les mesures. Lesdits capteurs sont couplés à l'objet d'étude par l'intermédiaire de coupleurs interchangeables permettant divers modes de fixation, d'où la possibilité de les placer pratiquement sur n'importe quelle partie du corps. Ce système correspond à un équipement de mesure biomécanique trouvant une application dans le domaine de la santé, son application pouvant s'étendre au domaine de la recherche.
Patent WO-2018026263-A2 (WO)
Title: Procédé d'extraction d'irisrésorcinol à partir de labisia pumila
Inventor: BIN SHUID AHMAD NAZRUN
IPC: A61K31/047
Filed: 2017-07-31
Abstract: L'invention concerne un procédé d'extraction du composé actif irisrésorcinol de Labisia pumila et l'utilisation dudit composé dans une préparation pharmaceutique. Le procédé se caractérise par les étapes consistant à obtenir un extrait à partir d'un matériau végétal de Labisia pumila en poudre au moyen d'une extraction aqueuse, à filtrer l'extrait pour obtenir un filtrat, à lyophiliser le filtrat pour obtenir un solide lyophilisé, à extraire le solide lyophilisé dans un solvant organique pour obtenir un extrait brut, à éliminer le solvant organique de l'extrait brut pour obtenir un extrait concentré, à extraire par chromatographie l'irisrésorcinol de l'extrait concentré et à purifier par chromatographie l'irisrésorcinol extrait.
Patent WO-2013169099-A2 (WO)
Inventor: ROODENBURG JOOP
IPC: E21B19/09
Filed: 2013-05-06
Abstract: The present invention relates to an offshore vessel capable of installing and removing a subsea well control device and a riser string, the vessel comprising a hoisting device comprising a travelling block for connecting a load, which travelling block is displaceable along a firing line which extends through a moonpool and a heave compensation system. The vessel further comprises a working deck supported by the hull of the vessel which covers at least a portion of the moonpool to allow the assembly of a riser string, wherein said working deck is provided with a riser string suspension device that allows to suspend a top end of a string of risers. According to the invention, a heave compensation connection system is provided, which is adapted to connect the working deck to the travelling block, such that the hoisting device can move the working deck when the working deck is connected to the travelling block between a lowered riser assembly position allowing the assembly of a riser string, and in which the working deck is supported by the hull, and a raised heave compensated position, in which the working deck is connected to the travelling block, and wherein the working deck is heave compensated.
Patent WO-2012030256-A2 (WO)
Title: Sensitizer for an erythrocytic diagnostic agent for diagnosing malignant neoplasms and method for producing same, erythrocytic diagnostic agent for diagnosing malignant neoplasms and method for producing same and method for diagnosing the presence of malignant neoplasms using said erythrocytic diagnostic agent
Inventor: BALYURA ALEXANDR VLADIMIROVICH
Filed: 2011-08-29
Abstract: The invention relates to medicine and concerns the diagnosis of oncological diseases, in particular the diagnosis of the presence of malignant neoplasms. A sensitizer is proposed for an erythrocytic diagnostic agent for diagnosing the presence of malignant neoplasms, said sensitizer comprising a mixture of fractions of low-molecular protein compounds with a molecular mass of 3000-15000 Da, which are extracted from the blood serum of a pregnant mare in the early stage of pregnancy and exhibit a stimulating effect on the proliferation of malignant cells. A method is also proposed for producing the aforesaid sensitizer from pregnant mare blood serum. An erythrocytic diagnostic agent sensitized with the aforesaid sensitizer is proposed as well as a method for producing same. Furthermore, a method for diagnosing the presence of malignant neoplasms using the aforesaid erythrocytic diagnostic agent is proposed. The claimed invention makes it possible to determine with a high degree of reliability whether a patient has malignant neoplasms and to conduct relatively rapid screening of large population groups in order to identify individuals who might have malignant neoplasms.
Patent WO-2014070042-A2 (WO)
Title: Leaf chain (variants)
Inventor: BONDARENKO ALEKSANDR LEONIDOVICH
IPC: F16G15/14
Filed: 2013-10-23
Abstract: The leaf chain comprises plates (1, 2) and hinges, wherein a chain hinge comprises a roller (3), a bush (4) and a resilient element (5), which connects the roller to the bush. Variant embodiments of the chain are possible in which the resilient element (5) is formed from plastic, is a composite, or is formed from rubber. The leaf chain can be in the form of a roller chain. The leaf chain with resilient elements can be formed without any bushes. The leaf chain can be in the form of a chain with two or more rows.
Patent WO-2009099396-A2 (WO)
Inventor: WANG RONG
IPC: B01D71/34
Filed: 2009-02-04
Abstract: The present invention provides a method for the production of a poly(vinylidene fluoride-co-hexafluoropropylene) (PVDF-HFP) asymmetric hollow fiber membrane. The invention comprises preparing a dope solution of PVDF-HFP with an additive of lithium chloride or glycerol dissolved in a solvent such as N-methylpyrollidone (NMP). The dope solution is spun to form a PVDF-HFP asymmetric hollow fiber membrane.
Patent WO-2011005217-A2 (WO)
Title: Method, system & services for electronic & physical business card design, procurement, printing, billing, electronic storage; and contact administration, management, exchange & tracking, for both individuals & organizations
Inventor: LEE ZEE SYE
IPC: B42D15/02
Filed: 2010-06-23
Abstract: A system (1000,1200), method (1300,1400,1500,1600,1700,1800) and service solution for enhancing business or name card design, procurement, electronic storage, contact management and exchange on a centralized, distributed and personal database over N-tier architecture. Users (1015,1018) are able to access the web server (1100) and the database server (1105) to obtain electronic business or name card and contact information. Users (1015,1018) can exchange the electronic business or name card and contact information through intranet, internet, telecommunication (3G or higher, MMS, SMS) and wireless mode (Bluetooth, infra-red, etc). Users (1035,1060) can scan business or name card and input contact information into their personal computers and database server (1105). Users (1035,1060) can engage (by subscribing to and requesting) a scanning service provider (1120) to scan the business or name card(s) and input contact information into the database server (1105), and subsequently Users (1035,1060) download and synchronize these information with user's personal computer (1030,1055) contact database manually or automatically through the system setting. Users (1035,1060) can also synchronize their mobile or portable devices' (handphone, smartphone, PDA, smartcard, wireless, etc) electronic business or name card and contact information with their computers (personal database, server database, internet database, email address book, web address book). Users (1035,1060) can also exchange electronic business or name card and contact information with each other and other contacts. Organization or Corporate Users (1025,1035) can design and make business or name card procurement through their company. A service provider (1075,1090) can edit, print and supply the printed business or name card, as well as, bill the user company accordingly. On the other hand, Public users (1050,1060) can design or select the design template from the system, and make business or name card procurement with a service provider (1075,1090), and make on-line payment directly or post-paid payment upon delivery of the business or name card and billing by the service provider. Additionally, the database server (1105) will store and link all old and new electronic business or name card and contact information indefinitely, such that the user's network of contacts such as friends, colleagues (current and former), business contacts, social contacts and those met once only shall still be able to retrieve and identify a lost contact using either an old or a new contact information of the said user.
Patent WO-2021061064-A2 (WO)
Title: Ultrasonic aeroponic indoor plant cultivation modules
Inventor: ÇİFTÇİ ERTAÇ
IPC: A01G31/06
Filed: 2020-07-30
Abstract: The invention relates to Ultrasonic Aeroponic Indoor Plant Cultivation Modules in which an ultrasonic aeroponic culture system is used.
Patent TR-2021005508-A2 (TR)
Title: El bagaj bölmesi̇ uv dezenfeksi̇yon si̇stemi̇
Inventor: MUHRİZ ONUR SAĞALTICI
IPC: A61L2/10
Filed: 2021-03-26
Abstract: Buluş, araçlarda, otobüslerde el bagaj bölmeleri (4) ile ilgili olup, özelliği; otobüs içindeki el bagaj bölmelerinin (4) kolay dezenfeksiyonunu sağlamak ve böylelikle virüs ve bakteri bulaşmasını önlemek için el bagajı bölmesinin (4) UV dezenfeksiyon sistemi oluşturmak üzere, el bagajı kapağı (1) kapatıldığında veya kapalı konumda bagaj algılandığında devreye giren ve el bagajı bölmesindeki (4) tüm bagajları dezenfekte eden en az bir UV lambası (2) içermesi ile karakterize edilir.
Patent TR-2021019451-A2 (TR)
Title: Gemiler İçin Tasarlanmış Bir Piezoelektrik Jeneratörü
IPC: H02N2/00
Filed: 2021-12-09
Abstract: Günümüz gemilerinde elektrik enerjisi ihtiyacı dizel yakıt kullanan jeneratörler ile karşılanmaktadır. Buluş, geminin deniz üzerinde sallanmasından enerji hasadı yaparak elektrik enerjisi üretecek, 1 adet dış gövde(1), 2 adet piezoelektrik maddeden yapılmış zemin ve tavan(3), 1 silindir(2), 2 yay(4) içeren bir piezoelektrik jeneratörü içermektedir.
Patent TR-2021019623-A2 (TR)
Title: ÇİZGİSEL VE DİSK KAYNAK FORMUNDA Pr-142 ORTA DOZ HIZLI / YÜKSEK DOZ HIZLI BRAKİTERAPİ RADYOİZOTOP KAYNAK ÜRETİM YÖNTEMİ
Inventor: HALUK YÜCEL
IPC: A61K51/00
Filed: 2021-12-10
Abstract: Mevcut buluş, kanser tedavisinde brakiterapi uygulamalarında kullanılmaya uygun çizgisel ve/veya disk kaynak formunda Pr-142 radyoizotop kaynağının üretim yöntemi ile ilgilidir. Buluşun yeniliği; praseodim metalik formunun veya praseodim oksitin (Pr2O3) en az bir formda hazırlanması; en az bir reaktörde yaklaşık 2,5x1012 n/cm2/s- termal nötron akısında, bir birinci süreyle ışınlanması ve net praseodim (Pr) miktarlarından MBq mertebelerinde Pr-142 radyoizotop beta kaynağının orta doz hızlı (MDR) veya yüksek doz hızlı(HDR) olarak üretilmesi adımlarını içermesidir.
Patent TR-2022007482-A2 (TR)
Title: Orman tahri̇bati ve kaçak avlanmayi önleyen bi̇r si̇stem
Inventor: SALİH ÇELİK
IPC: G08B19/00
Filed: 2022-05-09
Abstract: Söz konusu sistem (S), bir adet mini bilgisayar (1), bir adet kamera (2), bir adet motor (3), bir adet güneş paneli (4), bir adet akü (5), bir adet sesli alarm sistemi (6) içerir. Söz konusu sistem ile ormanların tahrip olmasının ve kaçak avlanmanın önüne geçilmesi hedeflenmektedir.
Patent WO-2004078926-A2 (WO)
Title: Marqueurs immunologiques
Inventor: ROOT-BERNSTEIN ROBERT
IPC: A61K47/42
Filed: 2004-02-27
Abstract: L'invention concerne des composés, des compositions et des méthodes d'identification d'humains ou d'animaux présentant une caractéristique particulière, par administration d'un marqueur antigénique induisant une réponse antigénique unique. Les compositions comprennent (a) un marqueur antigénique, et (b) un excipient acceptable d'un point de vue pharmaceutique, ledit marqueur n'induisant pas de réponse immunitaire de vaccination. Dans un mode de réalisation préféré, la composition comprend également un antigène de vaccination efficace contre les organismes tels que le Mycobacterium, le virus de l'immunodéficience humaine (VIH), l'hépatite C, le virus d'Espstein-Barr, le virus cytomégalovirus, l'E. coli, le virus de la leucose féline, la fièvre aphteuse, et le virus de la maladie de Carré. La présente invention concerne également des méthodes de suivi d'un sujet présentant une caractéristique donnée dans une population d'animaux. Le suivi s'effectue par administration d'un marqueur antigénique chez l'individu afin de produire des anticorps spécifiques au marqueur antigénique, puis par criblage de la population afin d'identifier l'individu en fonction de la présence des anticorps du marqueur.
Patent WO-2004082135-A2 (WO)
Title: Commande de puissance en boucle fermee de signaux a enveloppe non constante par echantillonnage-blocage
Inventor: GELS ROBERT G
IPC: H03G3/30
Filed: 2004-03-02
Abstract: L'invention concerne un système de commande de puissance de sortie radiofréquence destiné à être utilisé dans des systèmes de communication. Ce système de commande de puissance est utilisé pour un schéma de modulation ayant une enveloppe d'amplitude non constante et comprend un amplificateur de puissance ayant une entrée d'amplificateur de puissance permettant de recevoir un signal d'entrée avec une enveloppe d'amplitude non constante, une entrée de commande de puissance permettant de recevoir une entrée de commande de puissance, et une sortie d'amplificateur de puissance permettant de fournir un signal de sortie amplifié. Le système de commande de puissance peut également comprendre un circuit d'échantillonnage-blocage permettant de contrôler un signal de puissance de référence mesuré représentatif d'une modulation du signal d'entrée, et un moyen de soustraction permettant de soustraire une sortie du circuit d'échantillonnage-blocage au signal de puissance de référence mesuré pour fournir un signal de différence qui est couplé à l'entrée de commande de puissance.
Patent WO-2004083436-A2 (WO)
Inventor: MATHIS JONN P
IPC: C07K14/435
Filed: 2004-03-11
Abstract: The invention relates to Bt toxin resistance management. The invention particularly relates to the isolation and characterization of nucleic acid and polypeptides for a novel Bt toxin receptor. The nucleic acid and polypeptides are useful in identifying and designing novel Bt toxin receptor ligands including novel insecticidal toxins.